# Zero2IPO

> Zero2IPO is a VC fund in Beijing backing Education and Biotechnology. See 39 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 39
- Last investment: Jul 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/zero2ipo-group
- Website: http://www.zero2ipo.com.cn/en

Zero2IPO is a VC fund in Beijing focused on Education and Biotechnology. Founded in 1999, Zero2IPO is a leading integrated service provider in the China venture capital and private equity industry. Now, Zero2IPO has become an unbeatable dealflow and networking source in China. Zero2IPO's mission is to be the preferred service provider to businesses in the venture capital and private equity industry by offering anunparalleled knowledge and expertise to our clients and partners. To ensure this, Zero2IPO provides a broad and deep array of services enabling entrepreneurs and investors to reach the next level of success.Zero2IPO Group is headquartered in Beijing with offices in Shanghai, Shenzhen, Hong Kong, and Silicon Valley.

## Contacts

5 contacts available for Zero2IPO. Shizune tracks 2 team members at Zero2IPO. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/zero2ipo?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Angel | $425k–$15M |
| Series A | $2.8M–$25M |
| Series B | $16M–$59M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Education | 7 | 18% |
| Biotechnology | 6 | 15% |
| Manufacturing | 6 | 15% |
| Information Technology | 4 | 10% |
| Internet | 3 | 8% |

66 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 15 | 38% |
| Angel | 7 | 18% |
| Series B | 5 | 13% |
| Seed | 4 | 10% |
| Series C | 4 | 10% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 33 | 85% |
| United States | 2 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gavin Ni | Founder, Chairman & Chief Executive Officer | 0 | https://shizune.co/investors/profile/gavin-ni-0920 |
| Liu Yada | Investment Director | 1 | https://shizune.co/investors/profile/liu-yada |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Coremins | Coremins is a full-service provider of lithium battery HSI high shear insulating material spraying solutions. | $14.7M | Series A | Jul 10, 2026 |  |
| StarNuclear Fusion | StarNuclear Fusion is focused on the "high-temperature superconductivity + advanced quasi-isotropic propulsion (QI)" stellarator technology roadmap. | $122.3M | Series A | Jun 30, 2026 |  |
| SpinQ Technology | SpinQ Technology develops superconducting chip quantum computers, desktop nuclear magnetic resonance quantum computers, and quantum computing-related software. | $147.2M | Series D | Jun 30, 2026 |  |
| Topband Huachuang | Topband is a membrane material technology developer, mainly engaged in the research and development of special separation membrane materials. Its products are widely used in new energy, semiconductor, coal chemical and other fields. | $14.7M | Series C | May 26, 2026 |  |
| SPERIKON | SPERIKON is an innovative biotechnology company focusing on liquid reagents in cell biology. It is deeply involved in core scenarios such as cell biology research, cell medicine and drug development, cell health industry, and cell aesthetic medicine. With technological breakthroughs and industrialization capabilities, it provides high-qualityreagent products and full-chain services to the global cell biology field, promoting cell technology from the laboratory to clinical application and industrial implementation. | $14.7M | Series A | May 24, 2026 |  |
| Feimou Medical | FemtoMed is a developer of femtosecond laser treatment systems for ophthalmology, focusing on the clinical translation of femtosecond lasers in ophthalmic surgery. | $14.7M | Angel | Apr 19, 2026 |  |
| Shunheng Intelligence | Shunheng Intelligence focus on robotic technologies. |  | Angel | Mar 11, 2026 |  |
| Ruidong New Energy | Ruidong New Energy provides power systems for new energy and electric vehicles. The company specializes in the design and manufacture of power systems for new energy and energy-efficient automobiles. |  | Series A | Feb 06, 2026 |  |
| Huasai Biotechnology | Huasai Biotechnology develops microbial production of nucleotide-related raw materials utilizing synthetic biology technology. | $14.3M | Series A | Jan 04, 2026 |  |
| Essentia Biosciences | Essentia Biosciences is a biotechnology company that specializes in the development of cells, gene technology drugs, and medical devices. | $14.3M | Seed | Jan 01, 2026 |  |

10 of 39 investments shown.

## Co-investors
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 3 deals together
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 3 deals together
- [Innoangel Fund](https://shizune.co/investors/profile/innoangel-fund) — VC Fund, 3 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together
- [Flyfot Ventures](https://shizune.co/investors/profile/flyfot-ventures) — VC Fund, 2 deals together
- [Hengxu Capital](https://shizune.co/investors/profile/hengxu-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Galaxy Interactive](https://shizune.co/investors/profile/galaxy-interactive) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Education VC Funds in Asia](https://shizune.co/investors/education-vc-funds-asia)
- [Education VC Funds in China](https://shizune.co/investors/education-vc-funds-china)
- [Retail Investors in China](https://shizune.co/investors/retail-investors-china)
- [Art Investors in Asia](https://shizune.co/investors/art-investors-asia)
- [Art VC Funds in Asia](https://shizune.co/investors/art-vc-funds-asia)
- [Art Investors in China](https://shizune.co/investors/art-investors-china)

## FAQ

### What does Zero2IPO invest in?

Zero2IPO invests primarily in Education, Biotechnology and Manufacturing startups, most often at Series A and Angel stage. Most of the 39 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Zero2IPO's check size?

Zero2IPO typically joins rounds of $425k–$15M at Angel, $2.8M–$25M at Series A and $16M–$59M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zero2IPO participates in.

### How do I contact Zero2IPO?

Public channels for Zero2IPO include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Zero2IPO?

The team at Zero2IPO includes Gavin Ni (Founder, Chairman & Chief Executive Officer) and Liu Yada (Investment Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co